Answer
Priorix is indicated for active immunisation against measles, mumps and rubella in children aged 9 months or older, adolescents and adults, with specific guidance applying to children aged 9–12 months.
Sources for this answer
- Priorix powder and solvent for solution for injection in a pre-filled syringeGlaxoSmithKline UK · emc · SmPC §4.1 Therapeutic Indications · Version 32Document updated
Sources checked